Whatever the case, the fundamentals of a politically supportive backdrop for Novavax’s traditional approach to vaccines could easily boost NVAX stock under Trump’s second administration. With that in ...

President Joe Biden signed the Social Security Fairness Act into law, repealing old provisions that reduced the amount of Social Security retirement benefits for public sector workers who receive ...

The JPMorgan Equity Premium Income ETF (JEPI) had a fairly strong performance in 2024 as American equities delivered ...

Shares of Pfizer Inc. (NYSE:PFE – Get Free Report) were down 0.2% during trading on Friday . The company traded as low as $26 ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

To end the week, President Joe Biden effectively put an end to proposed the U.S. Steel (X)--Nippon merger, a move that sent the former stock reeling. As we prepare for a new administration to take the ...

Bullish option flow detected in Bristol Myers ( BMY) Squibb with 203,938 calls trading, 22x expected, and implied vol increasing over 5 points to 22.90%. Jan-25 52.5 calls and Jan-25 50 calls are the ...

ICU Medical's shares soared in 2024 with a strong rebound forecast. Read why ICUI stock remains intriguing for investors amid ...

By trading at a significant discount to its 2022 highs, Pfizer stock now offers investors a rare opportunity to buy this industry giant at a discount. Besides the price action, discounts are coming ...

Sangamo is on course to run out of money within months and has now lost access to up to $220 million in milestone payments ...

Pfizer gave Sangamo Therapeutics coal for Christmas, terminating a hemophilia A gene therapy pact to deprive the ...